Listen and follow our podcasts on:

This educational programme is supported by an Independent Medical Education Grant from Ipsen

In these two podcasts, medical experts and a patient representative share their perspectives on new Primary Biliary Cholangitis (PBC) data from EASL 2023.

In podcast 1, physicians Dr Emma Culver and Prof. Gideon Hirschfield discuss the evidence of cancer risk associated with PBC, how liver stiffness progression is associated with prognosis; and outcomes and response prediction in second-line therapy.

In podcast 2, CEO of the PBC Foundation, Robert Mitchell-Thain, and autoimmune specialist nurse Kath Houghton explore the impact of PBC symptoms and new instruments for assessing them. They also discuss data highlighting the importance of the current move toward normalisation of liver biomarkers and take a look at some early data on future therapies and therapeutic targets.

Transcripts, with details of the presentations covered, are available for download.

 

 

Clinical Takeaways

 

  • When treating people living with PBC, the goal is to aim for normal liver blood tests and normal quality of life

  • Emerging therapies are hoped to both significantly address biochemical and symptom control in PBC

  • Pruritus and fatigue can be devastating, and upcoming trials importantly are addressing alleviation of patient symptom burden as a priority

  • In the expected future treatment landscape, optimised markers of prognosis, response, and quality of life will become increasingly important

 

Consultant Hepatologist and Honorary Senior Lecturer at the John Radcliffe Hospital and University of Oxford. Clinical Lead for autoimmune and cholestatic liver disease in Oxford. National Committee Chair for UK-IgG4, Steering Committee for British Association for the Study of the Liver Immune-Mediated Liver Disease Special Interest Group and UK-PSC, and Scientific Committee for UK-AIH. Medical Advisory Board for the PBC Foundation and Scientific Advisory Board for PSC Support. Translational funding from the Welcome Trust, NIHR Academy of Medical Sciences, NIHR BRC Oxford, and Oxford Charitable Fund.

Dr Emma Culver has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Advisory Boards for Horizon Therapeutics, Zenus Biopharma, Sanofi, Moderna and Falk Pharma

Presenter fees for Falk Pharma, Horizon and Intercept.

Prof. Gideon Hirschfield has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Prof. Hirschfield received financial support/sponsorship from Advanz, Cymabay, Escient, GSK, Intercept, Ipsen, Miram and Pliant

Kath qualified as a nurse at Ormskirk Hospital, West Lancashire.  She gained experience in major abdominal and vascular theatres at both Ninewells Hospital in Dundee and at Heartlands Hospital in Birmingham.  In 2000 she joined the team at the Royal Victoria Infirmary in Newcastle upon Tyne as an endoscopy nurse before taking up a dual Nurse Specialist/research role with the Upper GI Regional Team at the Northern Oesophageal Gastric Cancer Unit. 

 

Since 2013 Kath has worked in the Hepatology Unit at the Freeman hospital, within the Newcastle Hospitals NHS Foundation Trust, where she has developed an interested in PBC. Currently she works in a dual role covering both research and as the first dedicated Autoimmune Liver Nurse Specialist within the trust, where she focused on patients with PBC.  Kath set up a nurse led PBC telephone clinic and helped to manage the PBC ODN.  She is also part of the PBC Connect educational cohort along with 2 consultants and 2 other nurse specialists from Cambridge, London, Birmingham and Oxford, helping to educate around PBC.

 

CEO at PBC Foundation, Chair of Global Liver Institute’s Paediatric and Rare Liver Disease Council and is also Chair of umbrella organisation, Liver Patients International. PBC Foundation is a UK-based international patient support and advocacy non-profit organisation that supports over 20,000 patients in over 80 countries around the world

Mr Robert Mitchell-Thain has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

The PBC Foundation has received funding from Advanz, Calliditas, Cara, Cymabay, Escient, GSK, Intercept, Ipsen, Mirum, and Umecrine.

Programme summary
Listen to the podcast now
Other episodes in this series
Primary Biliary Cholangitis Highlights from EASL 2023

Primary Biliary Cholangitis Highlights from EASL 2023

Episode 1: PBC Highlights from EASL

Primary Biliary Cholangitis Highlights from EASL 2023

Primary Biliary Cholangitis Highlights from EASL 2023

Episode 2: PBC Highlights from EASL 2023

Current Episode
Share this programme
This educational programme is supported by an Independent Medical Education Grant from Ipsen
Endorsement
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

Pediatric endocrinologists Podcast

Episode

2

of 2

episode
Rare diseases Pediatrics Endocrinology 
Short stature: Severe primary IGF-I deficiency (SPIGFD) – Episode 2

Diagnosis and management of classical and non-classical forms of primary IGF-I deficiency and overlapping syndromes

Experts
Prof. Andrew Dauber, Prof. Helen Storr
Endorsed by
The Magic Foundation
  • download Downloadable
    Resources
  • clock 25 MIN
  • calendar Dec 2023

Educational programme supported by an Independent Medical Education grant from Ipsen.
Podcast
Rare diseases Hemostasis and bleeding disorders 
Rare diseases: gene therapy and gene-modified cell therapies

Current role, potential and the example of hemophilia

Experts
Prof. Cedric Hermans, Prof. Miguel Escobar
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Dec 2023

Educational programme supported by an Independent Medical Education grant from American Society of Gene + Cell Therapy and Pfizer.
Podcast

Episode

1

of 2

episode
Pediatrics Endocrinology Rare diseases 
Short stature: Key challenges in diagnosis and management – Episode 1

Video podcast exploring primary IGF-I deficiency, GH deficiency and other rare growth disorders

Experts
Prof. Dr. Joachim Woelfle, Prof. Philippe Backeljauw
Endorsed by
The Magic Foundation
  • download Downloadable
    Resources
  • clock 33 MIN
  • calendar Dec 2023

Educational programme supported by an Independent Medical Education grant from Ipsen.
Endocrinology expert Video
Endocrinology Rare diseases 
Pituitary Updates from ECE & ENDO 2023

Prof. Maria Fleseriu provides 2023 conference data highlights

Experts
Prof. Maria Fleseriu
Endorsed by
Wapo
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Jul 2023

Educational programme supported by an Independent Medical Education grant from Ipsen.
Liver disease experts Podcast

Episode

1

of 2

episode
Rare diseases 
Primary Biliary Cholangitis Highlights from EASL 2023

Episode 1: PBC Highlights from EASL

Experts
Dr Emma Culver, Prof. Gideon Hirschfield, Ms Kath Houghton, Mr Robert Mitchell-Thain
Endorsed by
PBC
  • download Downloadable
    Resources
  • clock 30 MIN
  • calendar Jun 2023

This educational programme is supported by an Independent Medical Education Grant from Ipsen
Rare diseases Pediatrics Endocrinology 
Recognising and Diagnosing Severe Primary IGF-I Deficiency (SPIGFD)

A micro learning programme from paediatric endocrinologists

Experts
Prof. Philippe Backeljauw, Prof. Peter Bang
Endorsed by
TMF
HGF
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Feb 2023

Educational programme supported by an Independent Medical Education grant from Ipsen